Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Neuroprotection in Severe Traumatic Brain Injury Surgery
ChiCTR2200057513Phase 4Not yet recruiting
- Sponsor
- 904th Hospital of the Joint Logistic Support Force
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in traumatic brain injury (TBI) (3 arms), sponsored by 904th Hospital of the Joint Logistic Support Force. Primary endpoints: Inflammatory factors, Markers of brain injury and 1 more. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR2200057513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057513.